Telix Pharmaceuticals Limited is a biopharmaceutical company specializing in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals for oncology and rare diseases.
Ticker code: TLX
Sector: Healthcare | Industry: Biotechnology | Website: https://telixpharma.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $4,793,254,523 | $5,004,351,515 | 334724485 | 82.27 | $3,943,427,225 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $417,401,407 | $207,156,000 | $418,252,992 | 1.6 | 6.2 | 50.6 | 72.0 |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 7.5 | $14,555,635 | $28,018,640 | 10.85 | 18.6 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $14.320 | -1.9 | -0.9 | -6.5 | 3.8 | -44.0 | -41.5 |
TLX Price Chart with Volume and 3EMA
TLX Short Positions
Click HERE to understand why the above moving averages have been chosen.